Among pre-blended research peptide combinations, BPC-157 + TB-500 has become one of the most popular and widely studied in the tissue repair and recovery research space. Together, these two peptides address the full spectrum of the healing process — from growth factor signalling and vascular repair to cell migration and inflammation resolution — making them one of the most comprehensive repair research tools available.
02
What Are BPC-157 and TB-500?
TL;DR. BPC-157 is a gastric-juice-derived 15-amino-acid peptide; TB-500 is the active fragment of Thymosin Beta-4. Both are pre-clinical favourites for tissue repair, with different but complementary mechanisms.
BPC-157 — Body Protection Compound
BPC-157 is a synthetic 15-amino acid peptide derived from a naturally occurring protective protein found in human gastric juice. It has been studied extensively in pre-clinical models for its remarkable ability to accelerate healing across multiple tissue types — tendons, ligaments, muscles, bones, intestinal mucosa, and peripheral nerves. BPC-157 works primarily through upregulation of growth factor receptors, promotion of angiogenesis via VEGF signalling, and modulation of nitric oxide synthesis.
TB-500 — Thymosin Beta-4 Synthetic Fragment
TB-500 is a synthetic analogue of Thymosin Beta-4 — a naturally occurring 43-amino acid peptide found in virtually all human and animal cells. The key active sequence of Thymosin Beta-4 responsible for its healing effects — LKKTETQ — is preserved in TB-500. Its primary mechanism involves upregulation of actin, the protein that forms the cytoskeleton essential for cell movement. By promoting actin polymerisation, TB-500 accelerates the migration of endothelial cells, keratinocytes, and repair cells to sites of tissue damage.
03 · Work
How BPC-157 + TB-500 Work Together
📬
Stay Updated on Peptide Research
Latest research insights. No spam, ever.
TL;DR. The two peptides hit different parts of the repair sequence. BPC-157 = signals (growth factors, VEGF angiogenesis). TB-500 = cell mobilisation (actin dynamics, migration). They’re complementary, not redundant — which is why nearly every published repair-research stack uses both together.
The combination is more than the sum of its parts — the two peptides address different phases and mechanisms of the healing process:
Phase BPC-157 Role TB-500 Role Initiation Upregulates growth factor receptors, activates repair signalling cascades Promotes actin upregulation, prepares cells for migration Vascular repair Stimulates angiogenesis via VEGFR2, restores blood supply Promotes endothelial cell migration into damaged vasculature Inflammation Modulates NO synthesis, reduces pro-inflammatory signalling Reduces inflammatory cytokines, promotes M2 macrophage polarisation Tissue remodelling Promotes collagen organisation, fibroblast activity Accelerates keratinocyte migration, supports matrix remodelling
04 · Research
BPC-157 + TB-500 Research: Key Evidence
TL;DR. Three major published research areas: tendon/ligament healing, gut and intestinal repair, muscle regeneration. The Sikiric et al. group at Zagreb is the foundational research source.
Tendon and Ligament Healing
Both BPC-157 and TB-500 have independently demonstrated accelerated tendon healing in animal models. Studies on Achilles tendon transection in rats showed BPC-157 produced significantly faster functional recovery and superior collagen fibre organisation. TB-500 studies demonstrated improved tensile strength and cellular infiltration in damaged tendons. The combination is considered among the most powerful research tools for musculoskeletal repair investigation.
Gut and Intestinal Healing
BPC-157 has perhaps its strongest evidence base in gastrointestinal research. Multiple studies have demonstrated its ability to heal intestinal fistulas, reduce colitis severity, protect against NSAID-induced gut damage, and restore gut mucosal integrity. TB-500 complements this through its effects on gut epithelial cell migration and mucosal repair.
Muscle Repair
Research in skeletal muscle injury models has demonstrated accelerated fibre regeneration, reduced fibrosis, and improved functional recovery with both BPC-157 and TB-500 administration. The combination has become a standard research protocol in sports medicine and muscle biology research.
05 · Research
Research Dosing (Reference)
Research use only. Typical pre-clinical dosing is 250 mcg BPC-157 + 250 mcg TB-500 daily subcutaneous for 4–6 weeks. Always reference published protocols matched to the research endpoint. Not medical guidance.
For research reference only. Not approved for human use.
In animal research, BPC-157 has typically been dosed at 1-10mcg/kg and TB-500 at 2-5mg/kg, administered via subcutaneous injection. Emirates Peptides supplies BPC-157 + TB-500 as a pre-blended combination vial. Reconstitute with bacteriostatic water and use our peptide calculator.
Storage
Item 01
Lyophilised:
2-8°C, protect from light
Item 02
Reconstituted:
2-8°C, use within 28 days
06
Where to Buy BPC-157 + TB-500 in the UAE
✅ Pre-blended combination vial ✅ COA-verified, ≥99% purity on both components ✅ Fast delivery to Dubai, Abu Dhabi and all UAE emirates ✅ GCC shipping available ✅ Cash on delivery in Dubai
Order BPC-157 + TB-500 in UAE →
07 · Questions
Frequently Asked Questions
Why combine BPC-157 with TB-500 instead of using each alone?
The two peptides act on different parts of the tissue-repair sequence. BPC-157 drives growth factor signalling and angiogenesis; TB-500 drives cell migration via actin dynamics. Used together, they cover both halves of regeneration — sending the repair signal and delivering the cells that respond to it.
What is the typical research dose for BPC-157 + TB-500?
Published pre-clinical protocols typically use 250 mcg BPC-157 + 250 mcg TB-500 daily via subcutaneous injection for 4–6 weeks. Specific dose depends on the research endpoint — tendon and ligament studies use the higher end; gut studies use the lower end.
How long does the BPC-157 + TB-500 combo take to show effects in research models?
Tendon healing endpoints typically show measurable improvement within 2–3 weeks of daily dosing. Gut and intestinal repair endpoints accelerate within 7–14 days. Muscle regeneration and bone fracture endpoints span 4–8 weeks.
Is the pre-blended combo cheaper than buying separately?
Yes, the pre-blended vial is more cost-effective and convenient than purchasing BPC-157 and TB-500 separately. It also simplifies reconstitution — one vial, one bacteriostatic water volume, one syringe draw per dose.
Can BPC-157 + TB-500 be stacked with GHK-Cu?
Yes — this is the Glow Blend research stack: BPC-157 + TB-500 + GHK-Cu. Adding GHK-Cu brings collagen synthesis and gene expression activity to the existing tissue-repair mechanism set. The three peptides are commonly studied together in skin and tissue regeneration research.
Is BPC-157 + TB-500 legal in the UAE?
Both peptides are supplied strictly for laboratory research use and are not controlled substances in the UAE. Emirates Peptides ships the pre-blended combination vial with batch-specific HPLC certificates of analysis for both components.
How should the reconstituted BPC-157 + TB-500 vial be stored?
Refrigerated at 2–8 °C, protected from light, used within 28 days of reconstitution. Do not freeze — repeated freeze-thaw cycles fragment both peptides and destroy activity.
Disclaimer: For laboratory research use only. Not approved for human use. Not medical advice.
Explore Research-Grade Peptides
HPLC-verified, lab-tested peptides for your scientific research. Fast delivery across the UAE.
Browse All Peptides